Sugi Predict

Sugi Predict / Compounds / SCHEMBL19069934

SCHEMBL19069934

SCHEMBL19069934

CC(C)NCCNCC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ARG1 P05089 1/20 0.37
▸ ARG2 P78540 1/20 0.37
▸ HDAC1 Q13547 1/20 0.35
▸ ECE1 P42892 2/20 0.34
▸ CA1 P00915 4/20 0.33
▸ CA2 P00918 4/20 0.33
▸ GABRP O00591 2/20 0.33
▸ GABRD O14764 2/20 0.33
▸ GABRA1 P14867 2/20 0.33
▸ GABRB1 P18505 2/20 0.33
▸ GABRG2 P18507 2/20 0.33
▸ GABRB3 P28472 2/20 0.33
▸ GABRA5 P31644 2/20 0.33
▸ GABRA3 P34903 2/20 0.33
▸ GABRA2 P47869 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25553531 0.84 ECE1 (0.39) LMNAARG1ARG2HDAC1ECE1
SCHEMBL8664005 0.84 ALDH1A1 (0.38) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL4047031 0.84 EGLN1 (0.35) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL4063978 0.82 EGLN1 (0.34) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL25453161 0.82 ALDH1A1 (0.33) ALDH1A1TDP1ARG1ARG2
SCHEMBL25553023 0.81 LMNA (0.39) ALDH1A1LMNATDP1ARG1ARG2
SCHEMBL25554316 0.80 MAOA (0.45) LMNATDP1ARG1ARG2ECE1
SCHEMBL10988936 0.80 LMNA (0.44) LMNACA1CA2CTH
SCHEMBL163217 0.80 LMNA (0.44) LMNACA1CA2CTH
Hydrochloric Acid SCHEMBL1197241 0.78 MAOA (0.44) ARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ NATIONAL INSTITUTES OF HEALTH 2023-05-11 — — US disclosed
US-10407537-B2 Integrated zwitterionic conjugated polymers for bioelectronics, biosensing, regenerative medicine, and energy applications THE UNIVERSITY OF AKRON (US) 2019-09-10 — — US disclosed
US-20170327635-A1 INTEGRATED ZWITTERIONIC CONJUGATED POLYMERS FOR BIOELECTRONICS, BIOSENSING, REGENERATIVE MEDICINE, AND ENERGY APPLICATIONS THE UNIVERSITY OF AKRON (US) 2017-11-16 — — US disclosed
US-9695275-B2 Integrated zwitterionic conjugated polymers for bioelectronics, biosensing, regenerative medicine, and energy applications THE UNIVERSITY OF AKRON (US) 2017-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10407537-B2 Integrated zwitterionic conjugated polymers for bioelectronics, biosensing, regenerative medicine, and energy applications PCCA, PHOSPHO1, PC ALDH1A1 2160/4885LMNA 4398/4885MAPT 4743/4885
US-20170327635-A1 INTEGRATED ZWITTERIONIC CONJUGATED POLYMERS FOR BIOELECTRONICS, BIOSENSING, REGENERATIVE MEDICINE, AND ENERGY APPLICATIONS PCCA, PHOSPHO1, PC ALDH1A1 2160/4885LMNA 4398/4885MAPT 4743/4885
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ HAVCR2, CD44, ENGASE ALDH1A1 2185/4885LMNA 2333/4885MAPT 4460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.